This new Call marks an important step in a process which will result in the selection of six Expressions of Interest addressing future life sciences challenges for discussion with scientists and funding organisations at the second annual EuroBioForum, scheduled to take place on December 5-7 2007 in Lisbon, Portugal.
By bringing together key stakeholders in life sciences, EuroBioForum will set the scene for the future financing and implementation of new research programmes via public and/or private partnerships.
EuroBioForum 2007 follows on the success of the first annual EuroBioForum which took place in Helsinki on 14-15 December 2006.
That event had attracted over 150 participants from twenty five European countries, including representatives from national and intergovernmental research-funding organisations, leading research scientists, policy makers and representatives from the European Commission, foundations, industry and patient organisations.
Wouter Spek, the director of EuroBioFund, commented that “By seeking ideas for future research programmes from the key stakeholders in the area of life sciences, EuroBioFund aims to further develop the European Research Area”.
EuroBioFund, which was launched in June 2006, is focused on public or public/private consortia from the research, finance, industry, government and consumer/patient sectors that are aiming to develop and implement strategic research agendas. The coordinating body has three key objectives.
The first of these is to provide a platform for funding organisations and life science researchers to foster joint research initiatives through networking and brokerage.
The second goal is to help organise research communities and facilitate "bottom-up" Europe-wide research programs, via the newly-formed EuroBioGenerator.
Finally, the EuroBioFund is charged with shaping "a new funding way in Europe by helping to develop joint investments and funding of life sciences research," through the establishment of EuroBioAccess.
The ESF is an association of 75 member organisations devoted to scientific research in 30 European countries. Since its inception in 1974, it has coordinated a wide range of pan-European scientific initiatives.
The deadline for Expressions of Interest is 28 May 2007 17.00 CET. For further information see www.esf.org/eurobiofund/eoi or contact Dr. Wouter Spek at email@example.com or Dr. Fiona Kernan at firstname.lastname@example.org.
Thomas Lau | alfa
Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München
Second research flight into zero gravity
21.10.2016 | Universität Zürich
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences